Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0283 | 0.0283 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0283 | 0.0283 |
Brugia malayi | hypothetical protein | 0.0031 | 0.0879 | 0.2768 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0031 | 0.0879 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0283 | 0.0283 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0284 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2437 | 1 |
Brugia malayi | hypothetical protein | 0.002 | 0.0314 | 0.0147 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.144 | 0.5371 |
Trypanosoma brucei | beta lactamase | 0.0077 | 0.3313 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0031 | 0.0879 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0031 | 0.0879 | 0.1964 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0284 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0008 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2437 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0283 | 0.0283 |
Mycobacterium tuberculosis | Class a beta-lactamase BlaC | 0.0161 | 0.7677 | 1 |
Mycobacterium leprae | PROBABLE CONSERVED LIPOPROTEIN LPQF | 0.0077 | 0.3313 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0206 | 1 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein LpqF | 0.0077 | 0.3313 | 0.4097 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0284 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0283 | 0.0283 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0031 | 0.0879 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.144 | 0.5371 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2437 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.144 | 0.144 |
Leishmania major | hypothetical protein, conserved | 0.0031 | 0.0879 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0008 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0283 | 0.0283 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0031 | 0.0879 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2437 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0283 | 0.0283 |
Mycobacterium ulcerans | class a beta-lactamase, BlaC | 0.0161 | 0.7677 | 1 |
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0008 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0031 | 0.0879 | 1 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0284 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0284 | 0.0284 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0284 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0879 | 0.2768 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0283 | 0.0283 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0031 | 0.0879 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0283 | 0.0283 |
Schistosoma mansoni | hypothetical protein | 0.0206 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0206 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0283 | 0.0283 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0284 | 0.0284 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Poisoning activity at topoisomerase 1 (unknown origin) using 3'-[32P]dGTP labelled 117bp oligonucleotide assessed as induction of DNA cleavage at 1 uM incubated for 20 mins by SDS-PAGE analysis | ChEMBL. | 26890118 | |
Activity (binding) | Inhibition of human recombinant Top1-mediated DNA cleavage at 1 uM after 20 mins relative to camptothecin | ChEMBL. | 20630766 | |
Activity (binding) | = 0 | Inhibitory activity of compound against human recombinant DNA topoisomerase I mediated DNA cleavage; Greater activity | ChEMBL. | 11020283 |
Activity (binding) | = 100 % | Activity at recombinant Top1 (unknown origin) using 3'-[32P]-labeled double-stranded DNA (117 bp) as substrate assessed as suppression of DNA cleavage at 0.1 to 100 uM incubated for 20 mins by electrophoretic assay relative to 1 uM camptothecin | ChEMBL. | 26906474 |
GI50 (functional) | = 0.01 uM | Antiproliferative activity was determined for 50% growth inhibition against human lung HOP-62 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.01 uM | Antiproliferative activity was determined for 50% growth inhibition against human renal SN12C cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.01 uM | Antiproliferative activity was determined for 50% growth inhibition against human lung HOP-62 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.01 uM | Antiproliferative activity was determined for 50% growth inhibition against human renal SN12C cell line | ChEMBL. | 11020283 |
GI50 (functional) | > 0.01 uM | Antiproliferative activity against human SN12C cells | ChEMBL. | 18630891 |
GI50 (functional) | > 0.01 uM | Antiproliferative activity against human DU145 cells | ChEMBL. | 18630891 |
GI50 (functional) | < 0.01 uM | Cytotoxicity against human SN12C cells | ChEMBL. | 19783447 |
GI50 (functional) | < 0.01 uM | Cytotoxicity against human DU145 cells | ChEMBL. | 19783447 |
GI50 (functional) | < 0.01 uM | Cytotoxicity against human SN12C cells | ChEMBL. | 20630766 |
GI50 (functional) | < 0.01 uM | Cytotoxicity against human DU145 cells | ChEMBL. | 20630766 |
GI50 (functional) | < 0.01 uM | Cytotoxicity against human MCF7 cells | ChEMBL. | 20630766 |
GI50 (functional) | < 0.01 uM | Antiproliferative activity against human SN12C cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | < 0.01 uM | Antiproliferative activity against human DU145 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | < 0.01 uM | Antiproliferative activity against human MCF7 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | = 0.01 uM | Cytotoxicity against human SN12C cells by MTT assay | ChEMBL. | 26906474 |
GI50 (functional) | = 0.02 uM | Antiproliferative activity was determined for 50% growth inhibition against human Prostate DU-145 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.02 uM | Antiproliferative activity was determined for 50% growth inhibition against human Prostate DU-145 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.02 uM | Antiproliferative activity against human HOP62 cells | ChEMBL. | 18630891 |
GI50 (functional) | = 0.02 uM | Cytotoxicity against human HOP62 cells | ChEMBL. | 19783447 |
GI50 (functional) | = 0.02 uM | Cytotoxicity against human HOP62 cells | ChEMBL. | 20630766 |
GI50 (functional) | = 0.02 uM | Antiproliferative activity against human HOP62 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | = 0.02 uM | Growth inhibition of human HOP62 cells after 48 hrs by SRB assay | ChEMBL. | 24800942 |
GI50 (functional) | = 0.03 uM | Antiproliferative activity was determined for 50% growth inhibition against human melanoma UACC-62 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.03 uM | Antiproliferative activity was determined for 50% growth inhibition against human melanoma UACC-62 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.03 uM | Antiproliferative activity against human UACC62 cells | ChEMBL. | 18630891 |
GI50 (functional) | = 0.03 uM | Cytotoxicity against human UACC62 cells | ChEMBL. | 19783447 |
GI50 (functional) | = 0.03 uM | Cytotoxicity against human UACC62 cells | ChEMBL. | 20630766 |
GI50 (functional) | = 0.03 uM | Antiproliferative activity against human UACC62 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | = 0.04 uM | Antiproliferative activity against human SF539 cells | ChEMBL. | 18630891 |
GI50 (functional) | = 0.04 uM | Cytotoxicity against human SF539 cells | ChEMBL. | 19783447 |
GI50 (functional) | = 0.04 uM | Cytotoxicity against human SF539 cells | ChEMBL. | 20630766 |
GI50 (functional) | = 0.04 uM | Antiproliferative activity against human SF539 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | = 0.09 uM | Antiproliferative activity was determined for 50% growth inhibition against human CNS SF-539 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.09 uM | Antiproliferative activity was determined for 50% growth inhibition against human CNS SF-539 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.1 uM | Antiproliferative activity against human HCT116 cells | ChEMBL. | 18630891 |
GI50 (functional) | = 0.1 uM | Cytotoxicity against human HCT116 cells | ChEMBL. | 19783447 |
GI50 (functional) | = 0.1 uM | Cytotoxicity against human HCT116 cells | ChEMBL. | 20630766 |
GI50 (functional) | = 0.1 uM | Antiproliferative activity against human HCT116 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | = 0.15 uM | Antiproliferative activity was determined for 50% growth inhibition against human colon HCT-116 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.15 uM | Antiproliferative activity was determined for 50% growth inhibition against human colon HCT-116 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.5 uM | Antiproliferative activity against human OVCAR-3 cells | ChEMBL. | 18630891 |
GI50 (functional) | = 0.5 uM | Cytotoxicity against human OVCAR-3 cells | ChEMBL. | 19783447 |
GI50 (functional) | = 0.5 uM | Cytotoxicity against human OVCAR-3 cells | ChEMBL. | 20630766 |
GI50 (functional) | = 0.5 uM | Antiproliferative activity against human OVCAR3 cells by SRB assay | ChEMBL. | 21710981 |
GI50 (functional) | = 0.68 uM | Antiproliferative activity was determined for 50% growth inhibition against human breast MDA-MB-435 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.68 uM | Antiproliferative activity was determined for 50% growth inhibition against human breast MDA-MB-435 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 0.79 uM | Antiproliferative activity against human MDA-MB-435 cells | ChEMBL. | 18630891 |
GI50 (functional) | = 0.79 uM | Cytotoxicity against human MDA-MB-435 cells | ChEMBL. | 19783447 |
GI50 (functional) | = 1.5 uM | Antiproliferative activity was determined for 50% growth inhibition against human ovarian OVCAR-3 cell line | ChEMBL. | 11020283 |
GI50 (functional) | = 1.5 uM | Antiproliferative activity was determined for 50% growth inhibition against human ovarian OVCAR-3 cell line | ChEMBL. | 11020283 |
Inhibition (binding) | Inhibition of human DNA topoisomerase 1 assessed as induction of enzyme-dependent DNA cleavage relative to 1 uM camptothecin | ChEMBL. | 19783447 | |
Inhibition (binding) | Inhibition of recombinant DNA topoisomerase 1 (unknown origin) assessed as inhibition of topoisomerase 1-mediated DNA cleavage at 1 uM after 20 mins by SDS-PAGE analysis | ChEMBL. | 23987476 | |
Inhibition (binding) | > 95 % | Inhibition of recombinant human TOP1 mediated DNA cleavage after 20 mins by gel electrophoresis relative to camptothecin | ChEMBL. | 21710981 |
MGM (functional) | = 0.21 | Mean graph midpoint for growth inhibition of all human cancer cell lines | ChEMBL. | 11020283 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
7 literature references were collected for this gene.